Cargando…
Diagnostic and therapeutic pathways for the malignant left atrial appendage: European Heart Rhythm Association physician survey
AIMS: Patients with atrial fibrillation who despite taking oral anti-coagulant therapy (OAT) suffer a stroke or systemic embolism (SSE) without vascular cause or who develop left atrial appendage (LAA) thrombus (LAAT) should be considered as having malignant LAA. The optimal treatment strategy to re...
Autores principales: | Anic, Ante, Bakovic, Darija, Jurisic, Zrinka, Farkowski, Michal, Lisica, Lucija, Breskovic, Toni, Nielsen-Kudsk, Jens Erik, Perrotta, Laura, de Asmundis, Carlo, Boveda, Serge, Chun, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359107/ https://www.ncbi.nlm.nih.gov/pubmed/37440757 http://dx.doi.org/10.1093/europace/euad204 |
Ejemplares similares
-
Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey
por: Schwab, Ana Carolina, et al.
Publicado: (2022) -
Contemporary management of ventricular electrical storm in Europe: results of a European Heart Rhythm Association Survey
por: Baldi, Enrico, et al.
Publicado: (2022) -
Conduction system pacing in everyday clinical practice: EHRA physician
survey
por: Kircanski, Bratislav, et al.
Publicado: (2022) -
Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation
por: Januszkiewicz, Łukasz, et al.
Publicado: (2023) -
Regional disparity on patient characteristics and perceptions after implantable cardioverter-defibrillator implantation: results from an EHRA patient survey
por: Januszkiewicz, Łukasz, et al.
Publicado: (2023)